Home Blog Page 105

Blog

Pharma Marketing Blog

Most popular

FDA’s 2015 Guidance Agenda – Just Like the 2014 Agenda –...

Pharma Guy - January 7, 2015

3rd Party Dissemination of Altered Rx Drug Information on Social Media...

Pharma Guy - October 5, 2009

Selling Sickness: The War Against the Medical-Industrial Complex

Pharma Guy - February 22, 2013

Lyrica Lightens Up, DTCwise

Pharma Guy - July 24, 2008

Pharma Marketers Should Stop Blaming the FDA for Their Dysfunctional Social...

Pharma Guy - June 21, 2009

The Natrecor Waterboard Tortured Tchotchke

Pharma Guy - November 8, 2007

Barbie Drug Reps I’d Like to See

Pharma Guy - January 30, 2007

FDA’s BadAd Program Lacks Credible Evidence

Pharma Guy - May 11, 2011

Rozerem Beaver Buzz

Pharma Guy - September 14, 2006

Paula Deen Does Not Know Her Blood Sugar Numbers

Pharma Guy - April 12, 2012

1...104105106...240 Page 105 of 240

EDITOR PICKS

26th DTC National Conference

March 12, 2026

Informa Connect 2026 Events

January 19, 2026

FDA Pilots Are Changing Healthcare. Here’s What Pharma Marketers Should Do...

January 16, 2026

POPULAR POSTS

FDA Has Many Hurdles to Overcome in its Effort to Stem...

May 27, 2017

Advances in Genetic Medicine May Be Outpacing Some Clinicians’ Understanding, But...

December 21, 2020

Pharma Marketing News – Past Issues (2016)

January 1, 2017

RECENT POSTS

Researcher analyzing genetic data for an ultra-rare disease alongside physicians, DNA imagery, and patient silhouettes representing rare disease awareness and patient identification.

How Do You Market a Disease That Doesn’t Officially Exist?

August 6, 2026

Healthcare professional reviewing a plain-language clinical trial summary with a patient, illustrating how transparent communication strengthens trust, patient engagement, and pharmaceutical marketing.

The Plain-Language Revolution: How Compliance Is Becoming a Marketing Advantage

August 5, 2026

Healthcare professional reviewing a personalized medication dosing plan, illustrating flexible dosing strategies that support patient persistence and individualized treatment.

Could Flexible Dosing Become Pharma’s Next Competitive Advantage?

August 4, 2026